NICE TA875 recommends that specialist weight management services provide ongoing monitoring and support for patients prescribed anti-obesity medications
Mid-range dose
Ongoing monitoring: Regular check-ins with your provider allow for early intervention if weight begins to trend upward after discontinuation
Information Your Provider Needs To provide the best guidance, your healthcare provider will need detailed information about your health, medications, and lifestyle
Among responders, the degree of improvement varies from subtle symptom reduction to dramatic flare elimination, as illustrated by the Sjogren case report
Then, in 2022, a higher 2 mg dose gained approval, with clinical trials showing up to 73 percent of type 2 diabetic users achieving the recommended blood sugar levels of less than 7 percent, as recommended by the American Diabetes Association